Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1993 |
100 Clinical Results associated with Guangxi Shengbaotang Pharmaceutical Industry Co., Ltd.
0 Patents (Medical) associated with Guangxi Shengbaotang Pharmaceutical Industry Co., Ltd.
100 Deals associated with Guangxi Shengbaotang Pharmaceutical Industry Co., Ltd.
100 Translational Medicine associated with Guangxi Shengbaotang Pharmaceutical Industry Co., Ltd.